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Background
The events during host virus interaction pave the way to
differential outcomes in HIV-1 disease progression rates.
We have earlier shown that HIV-1Nef gene harbors target
sites for the human microRNA, miRNA 29a/b. Over
expression of miR 29a/b could reduce virus levels by tar-
geting the Nef gene. We hypothesized that differential
expression of the microRNA maybe a protective factor in
AIDS progression.
Methods
In a cohort of 75 HIV-1 infected individuals, who show
differential disease progression, classified as (1) Long
Term Non Progressors (LTNPs), (2) Regular Progressors
and (3) Rapid Progressors. We isolated RNA and DNA
from PBMCs collected from these individuals and healthy
controls. We quantified miR 29a expression through Real
Time PCR and performed statistical correlation of the
miRNA levels with disease progression rate. We further
analyzed miR 29a promoter and coding region from
selected patients.
Results
Patients, including various sub classes like LTNPs, Regular
Progressors and Rapid progressors, had higher miR 29a
levels than healthy controls. A small subset of patients had
unusually high levels of miR 29a. Three of these indivi-
duals were LTNPs while others were classified as regular
progressors.
Conclusion
The absence of known genetic causes of non progression
like the CCR5 delta mutation, in this patient cohort sug-
gests that there are novel mutations that confer protection.
The absence of healthy control individuals with high miR
29a expression suggests that the induction of miRNA
maybe happen in response to infection. However, larger
sample sizes are required to confirm this. We conclude
that miR 29a expression maybe one of the factors that in
certain backgrounds provides a better prognosis.
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